Literature DB >> 22281885

Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander?

Charikleia Christakou1, Frangiskos Economou, Sarantis Livadas, Christina Piperi, Christos Adamopoulos, Evangelos Marinakis, Evanthia Jdiamanti-Kandarakis.   

Abstract

OBJECTIVE: Advanced glycation end products (AGEs) activate the intracellular Nuclear Factor-κB pathway in endothelial cells, leading to production of endothelin-1 (ET-1), a peptide which causes endothelial dysfunction. The aim of the present study was to assess ΕΤ-1 and AGEs levels in women with polycystic ovary syndrome (PCOS) and controls and to investigate any potential relationship between them.
DESIGN: Metabolic and hormonal data from 75 women with PCOS and 25 controls, matched for age and ΒΜΙ were analyzed and correlated to AGEs and ET-1 levels.
RESULTS: Serum levels of ΕΤ-1 (1.55±0.13 vs. 0.37±0.10 pmol/l, p:0.003) and AGEs (8.34±1,81 vs. 5.77±0.78U/ml, p:0.002) were significantly higher in the PCOS group. ΕΤ-1 was correlated with AGES (r:0.54, p<0.001), Testosterone (r: 0.38, p<0.001), ΔΑ4 (r: 0.41, p<0.001) and FAI (r: 0.21, p<0.05). However, multiple linear regression analysis in the total study population showed that ΕΤ-1 was positively associated only with AGES (β: 0.22, p<0.001).
CONCLUSIONS: ET-1 levels were positively and strongly associated with AGEs in both PCOS women and controls, suggesting that the detrimental effect of AGEs on endothelial cells may involve increased ET-1 production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22281885     DOI: 10.14310/horm.2002.1320

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  8 in total

1.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

Review 2.  Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.

Authors:  Eman Y Gohar; Fernanda R Giachini; David M Pollock; Rita C Tostes
Journal:  Life Sci       Date:  2016-03-03       Impact factor: 5.037

3.  Serum galectin-3 levels in women with PCOS.

Authors:  H Yilmaz; H T Celik; O Ozdemir; D Kalkan; M Namuslu; S Abusoglu; C R Atalay; R Yigitoglu
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways.

Authors:  Christos Adamopoulos; Christina Piperi; Antonios N Gargalionis; Georgia Dalagiorgou; Eliana Spilioti; Penelope Korkolopoulou; Evanthia Diamanti-Kandarakis; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

5.  Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.

Authors:  Suttira Intapad; Norma B Ojeda; Elliott Varney; Thomas P Royals; Barbara T Alexander
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

6.  Frontostriatal White Matter Integrity Predicts Development of Delay of Gratification: A Longitudinal Study.

Authors:  Michelle Achterberg; Jiska S Peper; Anna C K van Duijvenvoorde; René C W Mandl; Eveline A Crone
Journal:  J Neurosci       Date:  2016-02-10       Impact factor: 6.167

7.  Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function.

Authors:  Takayuki Matsumoto; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  J Smooth Muscle Res       Date:  2021

8.  AGEs/RAGE blockade downregulates Endothenin-1 (ET-1), mitigating Human Umbilical Vein Endothelial Cells (HUVEC) injury in deep vein thrombosis (DVT).

Authors:  Yunxin Zhang; Jianlong Liu; Wei Jia; Xuan Tian; Peng Jiang; Zhiyuan Cheng; Jinyong Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.